BirchLEAF Miami 31 All Sold Out of EB-5 Visas

BirchLEAF Miami 31 All Sold Out of EB-5 Visas

At a time when the growth of the EB-5 visa program has led to reports of failed projects, misleading overseas marketing, and untrustworthy operators, it's refreshing to hear that perhaps not all is awry on the regional center front.

For BirchLEAF Miami 31 Regional Center, one might even say things have never been better. A short news releaseoffered by the regional center in February,2011 proclaims that "it has sold out its full allocation of subscriptions to foreign investors seeking their EB-5 visas."

That means the regional center has finished collecting the capital needed to fund its current EB-5 projects. What's more, the regional center's cornerstone project is associated with a very visible and well-known institution: The University of Miami.

"BirchLEAF Miami 31 Regional Center is making a $20 million EB-5 loan to the developer of Building 1 in the University of Miami Life Science and Technology Park," the press release states. The developer, Wexford Miami, LLC, will receive the loan in stages, the final sum being transferred sometime this summer.

In an email to, Ben Cummings, one of BirchLEAF's principals, said the regional center is nearly finished filing all its I-526's. "Our initial I-526's were filed last fall, so we are hopeful we will receive USCIS approvals of those at any time," he said.

A combination of financing from BirchLEAF Miami 31, banks, federal new market tax credits, and cash equity have helped fund construction of the new facility, which sits on university property.

The 8 acre site will include 1.65 million square feet of developed space, nearly all of which will be dedicated to biomedical research. It is located within the Miami Health District adjacent to the Miller School of Medicine. 

- As reported on Nov,2011 at


  • Florida

Securities Disclaimer

This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.